KFDA to Revise Regulations on Biological Drugs

Published: 2004-12-08 07:00:00

Updated: 2004-12-08 07:00:00

In an effort to bring the level of current regulations surrounding review and approval for use of current and future biological drugs to advanced international standards, the Korea Food and Drug Administration (KFDA) announced its plans to make significant revisions to existing guidelines, ultima...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK